Global Drug Delivery Market Segmentation, By Product Type (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), Application (Cancer, Diabetes, Respiratory Diseases, Cardiovascular Diseases, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
Drug Delivery Market Analysis
In recent years, the drug delivery market is anticipated to proliferate during the forecast period. According to the World Health Organization (WHO), chronic disease prevalence is expected to rise by 57% by the end of 2020, according to the World Health Organization (WHO). The desire for healthcare systems to focus more on advanced drug delivery technologies has risen rapidly in response to the rise in chronic diseases. Furthermore, there is a growing emphasis on product safety, efficacy, and patient-friendliness. The drug delivery market would increase in the approaching years due to the demand for sophisticated technologies to meet the rising demand for routine injectable pharmaceuticals to treat chronic illnesses.
Drug Delivery Market Size
Global drug delivery market size was valued at USD 1.85 billion in 2024 and is projected to reach USD 3.56 billion by 2032, with a CAGR of 8.50% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Drug Delivery Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Bausch Health Companies Inc. (Canada), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Merck & Co., Inc. (US), Cadila Pharmaceuticals. (India), Dr. Reddy's Laboratories Ltd. (India), 3M (US), Bayer AG (Germany), Astellas Pharma Inc. (Japan), AbbVie Inc. (US), Takeda Pharmaceutical Company Limited (Japan)
|
|
Market Opportunities
|
|
Drug Delivery Market Definition
Drug delivery introduces a therapeutic effect in a human's body by providing a drug to a certain targeted place. The safety and efficacy can be increased by adjusting the rate, time, and release of the drug in the body. Drugs can be delivered in a variety of ways, including oral, injectable, pulmonary, nasal, and other routes. The features of nanoparticles have been studied and used to develop drug delivery systems, which has made the process of drug distribution more efficient and time-saving.
Drug Delivery Market Dynamics
Drivers
- Rise in the prevalence of chronic diseases
The rising prevalence of chronic diseases is estimated to propel the drug delivery market's growth. Sedentary lifestyles have become commonplace as a result of rapid technological adoption. Obesity rates are rising as a result of this change in lifestyle, which is leading to a slew of chronic ailments such as diabetes and heart disease.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of drug delivery market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness and technological advancement will expand the drug delivery market. Additionally, high disposable income and increasing adoption of advanced drug administration systems will result in the expansion of drug delivery market. Along with this, rising geriatric population and rising demand for biosimilars and biologics will enhance the market's growth rate.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the drug delivery market growth. Along with this, rising drug approvals and launch of innovative products will further propel the market's growth rate.
Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of the drug delivery market during the forecast period.
Restraints/Challenges
On the other hand, the increasing number of drug recalls and drug failures will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the drug delivery market. Additionally, the risk of needle stick injuries will restrain and further impede the market's growth rate during the forecast period of 2025-2032.
This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Drug Delivery Market Scope
The drug delivery market is segmented on the basis of product type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Oral Drug Delivery
- Pulmonary Drug Delivery
- Injectable Drug Delivery
- Ophthalmic Drug Delivery
- Nasal Drug Delivery
- Topical Drug Delivery
- Implantable Drug Delivery
- Transmucosal Drug Delivery
Application
- Cancer
- Diabetes
- Respiratory Diseases
- Cardiovascular Diseases
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Drug Delivery Market Regional Analysis
The Drug delivery market is analyzed and market size insights and trends are provided by country, product type, application, end-users and distribution channel as referenced above.
The countries covered in the Drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the drug delivery market because of the presence of major key players and well-established healthcare infrastructure in this region. Additionally, the increase in the prevalence of chronic diseases and development of biologics and pharmaceutical drugs as well as devices will further propel the market's growth rate in this region.
Asia-Pacific are expected to grow during the forecast period due to the growing geriatric population and obtainability of self-administration in this region. Also, development of healthcare infrastructure will further propel the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Drug Delivery Market Share
The Drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to drug delivery market.
Drug Delivery Market Leaders Operating in the Market Are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Sanofi (France), Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Dr. Reddy's Laboratories Ltd. (India)
- Bausch Health Companies Inc. (Canada)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
- Merck & Co., Inc. (US)
- Cadila Pharmaceuticals. (India)
- 3M (US)
- Bayer AG (Germany)
- Astellas Pharma Inc. (Japan)
- AbbVie Inc. (US)
- Takeda Pharmaceutical Company Limited (Japan)
Latest Developments in Drug Delivery Market
- In March 2022, Sandoz, a Novartis division, announced the acquisition of a UK-based medical and drug delivery device company, Coalesce Product Development Limited. Sandoz acquired Coalesce's expertise and assets as part of the arrangement, which will help the company expand its respiratory medication portfolio and improve patient access to high-quality, complex therapeutics
SKU-